Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation. This blocks access to the study details from the page.SummaryDifference17%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows Revision: v3.6.5, replacing v3.6.4, indicating a small update to the study record page.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the study record on the page. This change reflects an update to the page's metadata rather than substantive content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page footer revision has been bumped to v3.6.3 from v3.6.2, signaling a small backend/template update rather than a change to trial details.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a minor site update; no study content or patient-facing information was changed.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.